BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
- Sponsor
- University of Chicago
- Study ID
- NCT07502365
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Financial Stress
- HIV
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 35 Years
- Healthy Volunteers
- Not accepted
Interventions
- Treatment As Usual — BEHAVIORALParticipants will go through a baseline survey. Participants will go through a follow-up survey every six months.
- BIG + Treatment As Usual — BEHAVIORALParticipants will go through a baseline survey. Participants will go through a follow-up survey every six months. Participants will also receive a $500 monthly income over an 18-month period.
Study Details
The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships. The main question it aims to answer is: Compared with the Treatment as Usual group, will participants in the BIG + Treatment as Usual group be more likely to improve care engagement and viral suppression? Participants on the study will be: * Randomly assigned (like the flip of a coin) to participate in either BIG + Treatment as Usual or Treatment as Usual. Participants will have an equal chance of being placed in either group. * Complete 9 surveys over a 36 month period. * Complete a release of information so electronic medical record data can be accessed for the 18 months prior to treatment engagement and for 36 months from program enrollment. * Participants in the Treatment as Usual group will not receive any intervention. * HIV viral load testing will be confirmed at 3 timepoints (baseline, 12 months, and 18 months). * Participants in the BIG + Treatment as Usual group will receive $500 monthly income for 18 months. * Participants in the BIG + Treatment as Usual group will complete 3 social network surveys to assess how receiving BIG impacts their social networks. * A subset of participants in the BIG + Treatment as Usual group (30 participants) will complete 5 individual interviews over the course of receiving BIG and the 18 months after.
Key Dates
- First listed
- Mar 31, 2026
- Start date
- Jul 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2030
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 304 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Treatment As UsualBaseline survey
- Experimental: Treatment As Usual plus Basic Income Guaranteed (BIG) InterventionBaseline survey and BIG intervention
Primary Outcome Measure
Retention in HIV care [ Time Frame: 18 months prior to baseline, to 36 months after baseline ]
Central Contacts
- Jordan Victorian773-702-5915
- Jade Pagkas-Bather
Find similar trials
Related Studies
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Viral Load in Blood and Lymph Tissues in People Living With HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressorsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland